Delivery Order SPE2DB24D1205-SPE2DB25FCZJK
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Latuda 60 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $5,418.64 and an ultimate completion date of September 11, 2025. The contract was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,987.00 firm fixed-price contract is for the delivery of Latuda 20 mg tablets, a prescription medication used to treat schizophrenia and bipolar disorder. The contract is not set aside and represents an individual delivery order under AmerisourceBergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Latuda 20 mg tablets in a quantity of 30 units. This competitive award, valued at $15,367.79, carries a firm fixed price structure with an ultimate completion date of August 29, 2025. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,574.29 firm fixed-price contract is for the supply of Latuda 20 mg tablets, a medication used to treat schizophrenia and bipolar disorder. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Latuda 60 mg, a medication used to treat bipolar disorder and schizophrenia, valued at $3,040.56. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by August 25, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count) with a ceiling value of $41,891.62. This firm fixed-price contract, awarded on September 8, 2025, with a completion date of September 9, 2025, represents a non-competitive set-aside delivery order issued under DLA's broader pharmaceutical procurement framework. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 2, 2025, for the supply of Latuda 60 mg tablets (30-count packaging) with a ceiling value of $6,445.00 under a firm fixed price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December 2026. The order is to be fulfilled...
- This is a $9,596.49 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Latuda 40 mg tablets and has a period of performance through July 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,529.39, is for the delivery of 4,567,872,178 units of the prescription medication Latuda 60 mg tablets. The contract has an ultimate completion date of April 11, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with...
- This is a $8,663.90 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of LATUDA 40 MG TABLET 30S, a pharmaceutical product. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a broad range of pharmaceutical and medical supply products to support military...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZJKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,115.27 to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. Latuda is an atypical antipsychotic medication commonly used to treat schizophrenia and bipolar disorder, reflecting the Defense Logistics Agency's continued procurement of specialized psychiatric pharmaceuticals to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) designated SPE2DX with the DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen Drug Corp leverages this comprehensive global contract vehicle to supply a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency operations and other federal healthcare systems worldwide. The company's established role as a critical pharmaceutical distributor positions it to efficiently fulfill tactical medical supply requirements across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.1k | 8/8/25 |